---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-026362"
form_type: "8-K"
ticker: "RXST"
cik: "0001111485"
company_name: "RxSight, Inc."
filed_at: "2022-12-12T23:59:59+00:00"
generated_at: "2026-06-21T05:57:00.448031+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# RxSight amends bylaws to update director nomination procedures and conform to Delaware law

## Summary
- Amended bylaws require stockholders nominating directors to provide evidence of compliance with Rule 14a-19 at least five business days before meeting.
- Revised stockholder meeting procedures and board action by written consent to conform to recent DGCL amendments.
- Updated provisions regarding directors, Board committees, and officers; made ministerial and conforming changes.
- Bylaw amendments effective December 9, 2022, approved by Board on recommendation of Corporate Governance and Nominating Committee.

## SEC filing metadata
- accession: 0000950170-22-026362
- form_type: 8-K
- ticker: RXST
- cik: 0001111485
- company_name: RxSight, Inc.
- filed_at: 2022-12-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1111485/000095017022026362/0000950170-22-026362-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1111485/000095017022026362/rxst-20221209.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-026362
- JSON: https://secwatch.observer/filing/0000950170-22-026362.json
- Plain text: https://secwatch.observer/filing/0000950170-22-026362.txt

## Key facts
- Governance Changes
  RxSight, Inc.: Amended and restated bylaws to revise director nomination procedures, stockholder meeting procedures, and conform to DGCL amendments (effective 2022-12-09).
  - Change: bylaw amendment
  - Effective: 2022-12-09
  source text: On December 9, 2022, the Board of Directors (the “Board”) of RxSight, Inc. (the “Company”), acting upon the recommendation of the Corporate Governance and Nominating Committee of the Board, amended and restated the Company’s amended and restated bylaws, effective immediately.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1111485/000095017022026362/0000950170-22-026362-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.